Chemotherapy with the use of next-generation tyrosine kinase inhibitors based on measurable residual disease has the potential to avoid hematopoietic stem cell transplantation in treatment for adults with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Cancer
; 129(10): 1523-1536, 2023 05 15.
Article
in En
| MEDLINE
| ID: mdl-36882308
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Hematopoietic Stem Cell Transplantation
/
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Type of study:
Guideline
/
Observational_studies
/
Prognostic_studies
/
Systematic_reviews
Aspects:
Patient_preference
Limits:
Adult
/
Humans
Language:
En
Journal:
Cancer
Year:
2023
Document type:
Article